Genta to Present at Lehman Brothers Healthcare Conference
(March 3)
BERKELEY HEIGHTS, N.J., Feb. 25 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA - News) announced that it will present at the Lehman Brothers Healthcare Conference in Miami Beach, FL. William P. Keane, Genta's Vice President and Chief Financial Officer, will provide an update on the Company's products and development programs on Wednesday, March 3, 2004 at 4:15 pm EST.
ADVERTISEMENT
A live audio webcast of the presentation can be accessed through Genta's Investor Relations site at: genta.com. A replay will be available approximately 24 hours following the presentation and will be available for 30 days thereafter.
About Genta
Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The Company's research platform is anchored by two major programs that center on oligonucleotides (RNA and DNA-based medicines) and small molecules. Genasense(TM) (oblimersen sodium), the Company's lead compound from its oligonucleotide program, is being developed with Aventis and is currently undergoing late-stage, Phase 3 clinical testing. The leading drug in Genta's small molecule program is Ganite(TM) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of patients with cancer-related hypercalcemia that is resistant to hydration. For more information about Genta, please visit our website at: www.genta.com. |
